{"organizations": [], "uuid": "da8d4afe7afe6ffe2e2e073b4a345192e49192b1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/5", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/03/business-wire-michael-giaquinto-joins-leerink-partners-investment-banking-team.html", "country": "US", "domain_rank": 767, "title": "Michael Giaquinto Joins LEERINK Partners Investment Banking Team", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-03T17:00:00.000+03:00", "replies_count": 0, "uuid": "da8d4afe7afe6ffe2e2e073b4a345192e49192b1"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/03/business-wire-michael-giaquinto-joins-leerink-partners-investment-banking-team.html", "ord_in_thread": 0, "title": "Michael Giaquinto Joins LEERINK Partners Investment Banking Team", "locations": [], "entities": {"persons": [{"name": "michael giaquinto", "sentiment": "neutral"}, {"name": "cohen", "sentiment": "none"}, {"name": "jed cohen", "sentiment": "none"}, {"name": "michael", "sentiment": "none"}, {"name": "greenhill", "sentiment": "none"}, {"name": "giaquinto", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "leerink partners investment banking team leerink partners", "sentiment": "neutral"}, {"name": "medical technology", "sentiment": "neutral"}, {"name": "citigroup", "sentiment": "none"}, {"name": "head of medical devices at greenhill & co", "sentiment": "none"}, {"name": "ubs", "sentiment": "none"}, {"name": "leerink partners", "sentiment": "none"}, {"name": "medical devices", "sentiment": "none"}, {"name": "u.s. healthcare group", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "LEERINK Partners extends Medical Technology franchise and further builds on Mergers & Acquisitions expertise\nBOSTON--(BUSINESS WIRE)-- LEERINK Partners, a leading healthcare investment bank, announced today that Michael Giaquinto has joined the investment banking team as a Senior Managing Director based in the firm’s New York office. Mr. Giaquinto will partner with Jed Cohen in leading the firm’s coverage of the Medical Devices sector. Mr. Giaquinto and Mr. Cohen had previously worked together for 13 years earlier in their careers.\nMr. Giaquinto brings to LEERINK Partners nearly three decades of healthcare investment banking experience, including 20 years of transactions focused on medical device companies. Prior to joining LEERINK Partners, Michael was the Head of Medical Devices at Greenhill & Co, where he spent the past 10 years dedicated exclusively to providing mergers and acquisition advisory services.\nPrior to Greenhill, Michael served as Co-Head of the U.S. Healthcare Group at Citigroup and also served as a Managing Director in the healthcare group at UBS. Michael has worked on more than 150 financing and M&A transactions valued at over $100 billion.\n“I have known Michael for more than 20 years and am thrilled to welcome him to LEERINK Partners,” said Jim Boylan, President and Head of Investment Banking. “Michael’s transaction experience, industry relationships and personal qualities make him a tremendous addition to our investment banking franchise. I look forward to partnering with Michael and am pleased to add yet another outstanding banker to our firm.”\n“LEERINK Partners is an exceptional fit for me given its exclusive focus on healthcare, the market leading capital markets franchise and strong partner-minded culture of the firm,” stated Michael Giaquinto. “I am excited to once again partner with Jed Cohen to further advance the medical device franchise and help our clients define and achieve their strategic and capital market objectives.”\nAbout LEERINK Partners\nLEERINK Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. LEERINK Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.leerink.com .\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180403005138/en/\nLEERINK Partners\nDiane Vieira, 617-918-4097\nor\nWeber Shandwick\nKate Contreras, 617-520-7088\nSource: LEERINK Partners", "external_links": ["https://www.businesswire.com/news/home/20180403005138/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.leerink.com&esheet=51781987&newsitemid=20180403005138&lan=en-US&anchor=www.leerink.com&index=1&md5=c72c90450fe2ada0d0e768f67c860d64"], "published": "2018-04-03T17:00:00.000+03:00", "crawled": "2018-04-03T17:35:26.000+03:00", "highlightTitle": ""}